Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.

Riley, Philip; Glenny, Anne-Marie; Hua, Fang; Worthington, Helen V.
Cochrane Database Syst Rev; 7: CD012744, 2017 07 31.
Artigo em Inglês | MEDLINE | ID: mdl-28759701

Documentos relacionados

  1. Insufficient evidence for interventions to prevent dry mouth and salivary gland dysfunction post head and neck radiotherapy.
  2. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
  3. PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS.
  4. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
  5. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer.
  6. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
  7. Correspondence.
  8. Reply: To PMID 25768249.
  9. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
  10. Histologic Improvements in Irradiated Bone Through Pharmaceutical Intervention in Mandibular Distraction Osteogenesis.